Hidradenitis suppurativa associated with Crohn’s disease and spondyloarthropathy: response to anti-TNF therapy
✍ Scribed by Maria Roussomoustakaki; Philippos Dimoulios; Constantinos Chatzicostas; Heraklis D. Kritikos; John Romanos; John G. Panayiotides; Elias A. Kouroumalis
- Publisher
- Springer Japan
- Year
- 2003
- Tongue
- English
- Weight
- 383 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: To investigate the contribution of multidrug resistance 1 (MDR1) gene pharmacogenetics (G2677T/A and C3435T) to the efficacy of azathioprine in inducing remission in patients with Crohn's disease (CD). ## Methods: A cohort of 327 unrelated Spanish patients with CD recruited from
Background: Infliximab (IFX) is an antitumor necrosis factor (TNF)-a antibody used to treat Crohn's disease (CD). However, antibodies to IFX (ATI) emerge, which can impair its efficacy. A fluid-phase enzyme immunoassay (FP-EIA) was established for measuring serum functional IFX (f-IFX) in CD patient
Background: Glucocorticoids and monoclonal antibodies to tumor necrosis factor reduce inflammation in Crohn's disease (CD). Rapid luminal healing, however, may promote intestinal stricture formation. The aim of this study was to examine fibrosis-associated gene expression in the intestine of patient